Lyme Handbook

Excerpted from Newswire Today  ( Posted: 06/02/2010 )

As Lyme disease increases at an alarming pace and fears that undiagnosed cases are creating a medical iceberg, scientists are working with speed and diligence to unlock the secret to a more effective test to head off an even wider medical crisis.

The challenge is to develop a test that is not only quick and accurate, but that is so sensitive that it cannot be fooled into failing to diagnose the illness, or to misdiagnose it as something else.

Scientists at TrovaGene, Inc., (formerly Xenomics, Inc.)a developer of transrenal molecular diagnostics, are now working on a non-invasive, urine-based test to diagnose and monitor various diseases and disorders, and which company officials say can be applied to the corkscrew-shaped bacterium Borrelia burgdorferi, better known as Lyme disease, and if successful, provide the most effective test available.

“We have begun research and expect significant results in 2011,” said Thomas Adams, TrovaGene’s Board Chairman.
“The critical distinction from existing tests is that the TrovaGene technology provides a more highly-sensitive method of detection by finding and analyzing “ultra short” (20-50 base pair) nucleic acids in a urine specimen.”
“Looking for these short DNA sequences should result in a highly reliable test for the disease,” said Adams.

The testing involves the collection of a urine sample from the patient, thus eliminating the need for an invasive blood drawing procedure.

For the full artucle:  http://www.newswiretoday.com/news/71371/

~ by Rob on June 3, 2010.

Posted in Lyme, Research Article
Tags: Bartonella, Lyme, Lyme Disease